Dr. David M. L. Rabin MD, PhD
Executive Director & Co-Founder
Dr. Rabin is the Co-Founder and Executive Director of the Board of Medicine, a nonprofit focused on democratizing health and treatment information by organizing and securing data to optimize public health. Dr. Rabin, a board-certified psychiatrist and translational neuroscientist, built and led a team of expert physicians and scientists to spearhead the development of the world’s first evidence-based peer-reviewed clinical guidelines for the safe use of medical cannabis and other complementary and alternative medicines. The Board of Medicine uses these guidelines to train and certify healthcare providers and industry partners, as well as to provide quality control standards for natural and currently unregulated medicines to support the community goals of high-quality clinical research and harm-reduction.
Dr. Rabin organized the world’s largest controlled study of psychedelic medicines (ongoing) in collaboration with colleagues at Yale, the University of Southern California, Mt. Sinai, I’Dor, Modern Spirit, and MAPS (Multidisciplinary Association of Psychedelic Studies) to determine the mechanisms of the dramatic therapeutic benefits observed following psychedelic-assisted psychotherapy in treatment-resistant mental illness. Biological specimens are being collected from the first cohort of 100 patients diagnosed with treatment-resistant PTSD in the MAPS FDA phase 3 double-blinded randomized placebo-controlled crossover trial that began in 2019.
Dr. Rabin is also the chief innovation officer, co-founder, and co-inventor at Apollo Neuroscience, Inc. In his role, Dr. Rabin is developing Apollo Neuroscience’s IP portfolio and organizing clinical trials of the Apollo technology; the first scientifically-validated wearable system to improve focus, sleep, and access to meditative states by delivering gentle layered vibrations to the skin. Dr. Rabin has been studying resilience and the impact of chronic stress in humans for over a decade. He has specifically focused his research on the clinical translation of non-invasive therapies that improve mood, focus, sleep, and quality of life in treatment-resistant illnesses. Dr. Rabin received his MD in medicine and PhD in neuroscience from Albany Medical College and trained in psychiatry at Western Psychiatric Institute & Clinic at the University of Pittsburgh Medical Center.
Lawton W Tang, MD
Co-Founder and Vice President of Board Of Medicine
Dr. Lawton W Tang continues to contribute to the body of literature of biomaterials being designed for skin, bone, and nerve regeneration, with a strong focus on polymeric materials, both native and synthetic. While in training he learned to isolate preadipocytes from human adipose tissue, and is exploring applications of these adult stem cells in soft tissue reconstruction. Of recent interest is the differentiation of preadipocytes into adipocytes, neural progenitor cells, and osteoblasts for tissue engineering applications.
Dr. Joseph Maroon MD, FACS
Board Member & Co-Founder
Joseph C. Maroon, MD, FACS is clinical professor and vice chairman of the Department of Neurological Surgery and Heindl Scholar in Neuroscience at the University of Pittsburgh Medical Center. In addition to being a renowned neurosurgeon, he is a sports medicine expert, health and nutrition expert and Ironman triathlete.
Dr. Maroon is regarded as a premiere specialist in the surgical treatment of injuries and diseases of the brain and spine, specializing in minimally invasive procedures. Consistently listed in America’s Best Doctors for the past 20 years, he has an international referral base, including numerous professional athletes and celebrities.
Dr. Maroon obtained his medical and neurosurgical training at Indiana University, Georgetown University, Oxford University in England and the University of Vermont. He conducted extensive research into neurotrauma, brain tumors and diseases of the spine, which has led to many innovative techniques for diagnosing and treating these disorders. His research efforts garnered him numerous awards from various national and international neurological societies.
Dr. Maroon is the author of six books, and (co-)author of 40 book chapters and over 270 published scientific papers. He has given more than 150 presentations at national and international conferences and is often invited as visiting professor and key-note speaker. He has served on the editorial boards of eight medical and neurological journals and is currently associate editor of Surgical Neurology, and editorial board member of Neurological Research and The Physician and Sports Medicine journals. He also is past-President of the Congress of Neurological Surgeons, the largest society of Neurosurgeons in the world.
Dr. Maroon has been the team neurosurgeon for the Pittsburgh Steelers since 1981, and is Medical Director of the World Wrestling Entertainment (WWE). He has successfully performed surgery on numerous professional football players and other elite athletes with potentially career-ending neck and spine injuries. Notably, he safely returned most to their high level of athletic performance.
Dr. Maroon is highly invested in the prevention and treatment of concussions in high school, college and professional sports, specifically football. While working with the Steelers in the early 1990’s, the lack of an objective, reliable instrument to evaluate concussion symptoms became very apparent to Dr. Maroon. To fill this void, he and Dr. Mark Lovell developedImPACT™ (Immediate Post-Concussion Assessment and Cognitive Testing), an easy-to-administer, 20 minute long test to assess presence and severity of concussion symptoms. ImPACT™ has become the world-wide standard tool to assess sports-related concussions, and has been used in over 4.5 million athletes. In 1994, Dr. Maroon joined the National Football League’s mild Traumatic Brain Injury Committee as concussion expert. This committee, which in 2007 was renamed National Football League’s Head, Neck and Spine Committee, is still in place.
For his expertise on sports medicine and concussions, Dr. Maroon is frequently interviewed and quoted by the media, including the New York Times, USA Today, Associated Press, ESPN, Sports Illustrated, and ABC News Nightline.
Dr. Ben Kelmendi MD
Ben is a psychiatrist and an Associate Professor in the Department of Psychiatry at the Yale University School of Medicine. His primary clinical expertise is in PTSD, Depression, OCD, and the endocannabinoid system. He is the co-founder of the Yale Psychedelic Science Group. He leads a research program focused on the therapeutic potential of psychedelic medicines, across a range of psychiatric diagnosis. He is currently investigating the effects of psilocybin on the neurocircuitry implicated in the development, maintenance, and treatment of patients with OCD. He is also exploring the effects of MDMA on brain activation and neural network organization in PTSD to understand the relationship between MDMA-induced neural changes and the acute cognitive and behavioral effects of the drug.
Dr. Patrick Driscoll MD
Dr. Henry Driscoll is a pediatric, adolescent, and adult psychiatrist with a focus on substance use disorders and psychoanalysis. Early in his training, Dr. Driscoll started his journey in medicine and healing with a deep interest in holistic approaches to health and wellness. A student of the mind and thinking, he studied philosophy as an undergraduate which led to his choice of neuroscience and psychiatry as ways to most positively impact the health and well-being of patients in a career in medicine.
His early research in the biology of aging at the National Institute on Aging included several peer-reviewed papers from the Laboratory of Molecular Gerontology under Drs. Robert Brosh, PhD and Wilhelm Bohr, MD, PhD. He completed his medical training as a Dean’s merit scholar at the University of Pittsburgh School of Medicine where he also completed a masters degree in clinical research with Dr. Charles Reynolds in his laboratory for the study of sleep, pharmacotherapy, and treatment-resistant late-life depression. He completed his psychiatric residency at Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center including a fellowship in child and adolescent psychiatry and a clinical focus in addiction medicine. This broad clinical experience with patients across the lifespan positions him well to communicate about our most current knowledge of how, to paraphrase Hippocrates, to use our food as remedies and make remedies of our foods. He has also contributed to several books and training manuals on doctor-patient engagement including co-authoring Humanizing Addiction Treatment with Antoine Douaihy, MD.
Dr. Driscoll found his calling in clinical work with young people and their families which is the primary focus of his current practice in Pittsburgh. As a dedicated educator who has earned top teaching awards from the University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, he continues his work in the use of collaborative therapeutic inquiry into all layers of thought and experience within the doctor-patient relationship as an advanced candidate at the Pittsburgh Psychoanalytic Center.
Dr. Bryan Donohue
Dr. Donohue is an interventional cardiologist now in practice for thirty years. He attended the Georgetown University School of Medicine and trained in Internal Medicine at the University of California, San Francisco, in Cardiology at the University of California, Los Angeles and in Interventional Cardiology at the Andreas Gruentzig Center of the Emory University School of Medicine. His research has centered on the care of patients with acute myocardial infarction and in collaboration with other leading cardiologists this work has lead to a nationwide change in the treatment these patients receive with marked improvements in their outcomes. This clinical research has been published in leading peer reviewed journals including the New England Journal of Medicine, the Journal of the American College of Cardiology and Circulation and he has been an invited speaker on this work both nationally and internationally. He has been asked to chair scientific presentations at the American College of Cardiology Annual Scientific Sessions, received a Fulbright Scholarship Award and been recognized locally as heart doctor of the year and cited as among the best heart doctors for women. His professional interests additionally include the athletic heart and he consults extensively with the World Wrestling Entertainment (W.W.E.) in that context. Over the recent years he has extensively studied the cardiovascular benefits of plant based compounds and founded a nutritional supplement company to make available to the public particular phytochemicals that researchers have identified as central to lowering vascular risk . The purity of the product and insuring that methods of production are as rigorous as those in the pharmaceutical industry have been central in the foundation and development of this naturiceutical company.